Non-inferiority trials have become an essential instrument in clinical research, particularly when the goal is to demonstrate that an experimental treatment is not unacceptably worse than an ...
MedPage Today on MSN
Active Surveillance for DCIS Moves Closer to Standard Option but 'Not Quite There'
Large randomized trial makes case for non-inferiority versus surgery; smaller study falls ...
MedPage Today on MSN
Watchman LAA occluder bounces back as alternative to OAC in CHAMPION-AF
Study suggests a path forward for device therapy, though caveats are plenty ...
ONS-5010 shows non-inferiority to Lucentis at 12 weeks; BLA resubmission planned for Q1 2025, with $20.4M in proceeds expected. ONS-5010 demonstrated non-inferiority to ranibizumab at week 12, ...
Randomized controlled trial of the efficacy of lymph node dissection on stage IIICr of cervical cancer (CQGOG0103). Background: Minimally invasive surgery (MIS) is associated with improved ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)--Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious ...
Functional impairments, fatigue, and pain in newly diagnosed solid-tumors: Retrospective path analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results